Clive King

Title: Clive King: Innovator in Pharmaceutical Development

Introduction

Clive King is a notable inventor based in Middlesex, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of highly purified compounds. With a total of 3 patents to his name, Clive has established himself as a key figure in pharmaceutical innovation.

Latest Patents

Clive King's latest patents focus on the production and purification of pharmaceutical-grade compounds. One of his notable inventions includes methods for producing Active Pharmaceutical Ingredient (API) grade migalastat hydrochloride. He has also developed methods for purifying intermediate grade migalastat hydrochloride. Additionally, Clive has worked on producing [(2R,3S,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol hydrochloride (lucerastat hydrochloride) and other 1-deoxygalactonojirimycin compounds, along with methods for purifying these compounds.

Career Highlights

Clive is currently employed at Amicus Therapeutics, Inc., where he continues to push the boundaries of pharmaceutical research. His work has been instrumental in advancing the production of critical compounds that have significant therapeutic potential.

Collaborations

Throughout his career, Clive has collaborated with talented individuals such as James Cartwright and Wendy Cross. These partnerships have fostered an environment of innovation and have contributed to the success of his projects.

Conclusion

Clive King's contributions to the pharmaceutical industry through his innovative patents and collaborations highlight his role as a leading inventor. His work continues to impact the field positively, paving the way for future advancements in pharmaceutical development.